Does GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS Cause Off label use? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Off label use have been filed in association with GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS. This represents 16.1% of all adverse event reports for GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS.
14
Reports of Off label use with GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS
16.1%
of all GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS reports
3
Deaths
2
Hospitalizations
How Dangerous Is Off label use From GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS?
Of the 14 reports, 3 (21.4%) resulted in death, 2 (14.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does GENETICALLY-MODIFIED AUTOLOGOUS T CELLS NOS Cause?
Disease progression (28)
Lymphoma (17)
Cytokine release syndrome (16)
Neutropenia (9)
Plasma cell myeloma refractory (9)
Pyrexia (8)
Atrial fibrillation (5)
Covid-19 (5)
Death (5)
Malignant neoplasm progression (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)